THURSDAY, Dec. 26, (2024 HealthDay News) — The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people living with Type 2 diabetes. Liraglutide, the generic for Victoza, is similar to semaglutide, the active ingredient inContinue Reading
MONDAY, Dec. 23, 2024 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound. In a news release published Dec. 20, the FDA stated that Zepbound, part of the GLP-1 receptor agonist medicinesContinue Reading
THURSDAY, Dec. 19, 2024 (HealthDay News) — The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over. Tirzepatide includes blockbuster injected GLP-1 medications Mounjaro (for diabetes) and Zepbound (for weight loss). The FDA firstContinue Reading
FRIDAY, Dec. 13, 2024 (HealthDay News) — The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of GLP-1 weight-loss meds, a new study finds. Data on almost 17 million adults nationwide showed the obesity rate — which has been rising forContinue Reading
THURSDAY, Dec. 12, 2024 (HealthDay News) — Unhealthy ultra-processed foods have wormed their way into American kitchens, likely harming people’s health for decades, a new study warns. More than half of the calories adults eat at home now come from ultra-processed foods, which contain high levels of sugar, salt, fatContinue Reading
TUESDAY, Dec. 10, 2024 (HealthDay News) — People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their odds for a dangerous blood clot, new research finds. The study found that folks with diabetes who were using the drugsContinue Reading
FRIDAY, Dec. 6, 2024 (HealthDay News) — Americans are falling farther behind the rest of the developed world when it comes to health and life expectancy, a new study shows. Life expectancy in the United States is expected to increase to 79.9 years in 2035 and 80.4 years by 2050,Continue Reading
FRIDAY, Dec. 6, 2024 (HealthDay News) — Eating lots of ultra-processed foods appears linked to a buildup of fat in the thighs, which in turn raises a person’s odds for arthritis in the knees, new research shows. “In an adult population at risk for but without knee or hip osteoarthritis,Continue Reading
THURSDAY, Dec. 5, 2024 (HealthDay News) — The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs’ cost should be covered by Medicare, Medicaid and private insurers. Late last month, the Biden administration proposed that the drugs be covered by MedicareContinue Reading
THURSDAY, Dec. 5, 2024 (HealthDay News) — Fatty liver disease may contribute to fragmented sleep patterns, robbing already sick people of good rest, a new study finds. These folks woke up more often in the night, and then lay awake longer waiting for slumber to reclaim them, researchers found. TheseContinue Reading